DYNAVAX TECHNOLOGIES CORP (DVAX) Forecast, Price Target & Analyst Ratings
NASDAQ:DVAX • US2681582019
15.5 USD
0 (0%)
At close: Feb 9, 2026
15.5 USD
0 (0%)
After Hours: 2/9/2026, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DYNAVAX TECHNOLOGIES CORP (DVAX).
Forecast Snapshot
Consensus Price Target
$20.91
+ 34.90% Upside
Next Earnings Forecast
Release DateFeb 18, 2026
PeriodQ4 / 2025
EPS Estimate$0.04
Revenue Estimate81.867M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$20.91
Upside
+ 34.90%
From current price of $15.50 to mean target of $20.91, Based on 9 analyst forecasts
Low
$16.16
Median
$20.91
High
$26.25
Price Target Revisions
1 Month
-1.20%
3 Months
-14.58%
Price Target Summary
9 analysts have analysed DVAX and the average price target is 20.91 USD. This implies a price increase of 34.9% is expected in the next year compared to the current price of 15.5.
The average price target has been revised downward by 14.58% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
DVAX was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about DVAX.
In the previous month the buy percentage consensus was at a similar level.
DVAX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-24 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-08-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-08-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-05-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-04-17 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-02-21 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-02-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2025-01-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-01 | Goldman Sachs | Initiate | Neutral |
| 2023-11-03 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-11-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-04 | JMP Securities | Maintains | Outperform -> Outperform |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-03 | JMP Securities | Maintains | Outperform |
| 2023-05-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-24 | JMP Securities | Maintains | Market Outperform |
| 2023-02-24 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateFeb 18, 2026
PeriodQ4 / 2025
EPS Estimate$0.04
Revenue Estimate81.867M
Revenue Q2Q15.22%
EPS Q2Q-25.19%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
1.54%
EPS (1 Month)
0.00%
EPS (3 Months)
-45.00%
Next Earnings Summary
DVAX is expected to report earnings on 2/18/2026. The consensus EPS estimate for the next earnings is 0.04 USD and the consensus revenue estimate is 81.87M USD.
The next earnings revenue estimate has been revised upward by 1.54% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 722.7M 64.47% | 232.284M -67.86% | 277.246M 19.36% | 345.52M 24.63% | 400.27M 15.85% | 460.37M 15.01% | 534.01M 16.00% | 580.53M 8.71% | 632.4M 8.93% | 838.44M 32.58% | 921.06M 9.85% | |
| EBITDA YoY % growth | 288.5M 106.51% | -29.705M -110.30% | 505K 101.70% | 25.021M 4,854.65% | 33.043M 32.06% | 45.056M 36.36% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 284.7M 110.27% | -34.047M -111.96% | -4.122M 87.89% | 9.727M 335.98% | 50.201M 416.10% | 84.31M 67.94% | 135.89M 61.18% | 166.69M 22.67% | 184.72M 10.82% | N/A | N/A | |
| Operating Margin | 39.39% | -14.66% | -1.49% | 2.82% | 12.54% | 18.31% | 25.45% | 28.71% | 29.21% | N/A | N/A | |
| EPS YoY % growth | 1.97 479.41% | -0.06 -103.05% | 0.18 400.00% | -0.39 -318.17% | 0.54 236.88% | 0.78 45.35% | N/A | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.04 -25.19% | 0.08 1,484.47% | 0.17 22.89% | 0.23 7.83% | 0.07 84.07% | 0.18 131.75% | 0.30 71.93% | 0.32 39.64% | 0.18 166.67% |
| Revenue Q2Q % growth | 81.867M 15.22% | 86.373M 26.71% | 107.62M 12.76% | 116.46M 22.75% | 92.499M 12.99% | 115.58M 33.81% | 136.08M 26.44% | 139.68M 19.94% | 111.24M 20.26% |
| EBITDA Q2Q % growth | 6.417M 114.26% | -7.598M 66.17% | 9.038M -46.34% | 31.957M 27.95% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.561M -56.90% | -389.64K 98.35% | 16.853M 16.80% | 28.057M 31.90% | 2.244M 187.64% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
63.12%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
17.54%
Revenue Next 5 Year
15.42%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
103.78%
EBIT Next 5 Year
N/A
DYNAVAX TECHNOLOGIES CORP / DVAX Forecast FAQ
Can you provide the average price target for DYNAVAX TECHNOLOGIES CORP stock?
9 analysts have analysed DVAX and the average price target is 20.91 USD. This implies a price increase of 34.9% is expected in the next year compared to the current price of 15.5.
Can you provide the upcoming earnings date for DYNAVAX TECHNOLOGIES CORP?
DYNAVAX TECHNOLOGIES CORP (DVAX) will report earnings on 2026-02-18, after the market close.
What are the consensus estimates for DYNAVAX TECHNOLOGIES CORP (DVAX) next earnings?
The consensus EPS estimate for the next earnings of DYNAVAX TECHNOLOGIES CORP (DVAX) is 0.04 USD and the consensus revenue estimate is 81.87M USD.
Can you provide the expected long term growth rate for DYNAVAX TECHNOLOGIES CORP stock?
The expected long term growth rate for DYNAVAX TECHNOLOGIES CORP (DVAX) is 17.54%.